OMEROS CORP Prepaid Expense and Other Assets
OMEROS CORP (OMER) had Prepaid Expense and Other Assets of $4.20 million as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Balance Sheet › Assets
us-gaap:PrepaidExpenseAndOtherAssets · last filed 2019-05-09
- 2019-03-31: Prepaid Expense and Other Assets $4.20M.
- 2018-12-31: Prepaid Expense and Other Assets $6.46M.
- 2016-06-30: Prepaid Expense and Other Assets $1.03M.
- 2015-06-30: Prepaid Expense and Other Assets $68.00K.
| Period end | Prepaid Expense and Other Assets |
|---|---|
| 2019-03-31 | $4.20M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $6.46M 10-Q · filed 2019-05-09 |
| 2016-06-30 | $1.03M 10-Q · filed 2016-08-09 |
| 2015-06-30 | $68.00K 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |